Detail description

This page displays user query in tabular form.

2116 details
Primary information
CancerPPD ID2116
PMIDNone
YEAR2005
SEQUENCEILPWKWPWWPWRR
LENGTH13
NAMEIndolicidin
C-ter ModificationAmidation
N-ter ModificationFree
Linear/CyclicLinear
L/D/MixL
Non-NaturalNone
NATUREAnticancer
ACTIVITYLD50 =200 µg/ml
SOURCEFLAK peptides
Cancer TypeSkin Cancer
ASSAYMTT/MTS assay
Patent IDUS_06875744_B2
TissueSkin
CELL LINEBMKC
TEST TIME24-h
Secondary information
STRUCTURE
Predicted Structure
DSSP statesCCCSCCSSCCCCC
SMILES[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C
External Links
PDB exactPDB partialSP exactSP partialTrEMBL exactTrEMBL partialIEDB exactIEDB partial
NANANANANANANANA